T. Rowe Price Associates
WST icon

T. Rowe Price Associates’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25.7M Sell
117,629
-37,122
-24% -$8.12M ﹤0.01% 897
2025
Q1
$34.6M Sell
154,751
-370,568
-71% -$83M ﹤0.01% 823
2024
Q4
$172M Sell
525,319
-736,159
-58% -$241M 0.02% 457
2024
Q3
$379M Sell
1,261,478
-432,349
-26% -$130M 0.04% 320
2024
Q2
$558M Sell
1,693,827
-339,063
-17% -$112M 0.07% 252
2024
Q1
$804M Sell
2,032,890
-294,504
-13% -$117M 0.1% 192
2023
Q4
$820M Sell
2,327,394
-179,742
-7% -$63.3M 0.11% 182
2023
Q3
$941M Sell
2,507,136
-330,808
-12% -$124M 0.14% 153
2023
Q2
$1.09B Sell
2,837,944
-4,757
-0.2% -$1.82M 0.15% 144
2023
Q1
$985M Buy
2,842,701
+541,540
+24% +$188M 0.15% 152
2022
Q4
$542M Sell
2,301,161
-1,568,961
-41% -$369M 0.09% 215
2022
Q3
$952M Sell
3,870,122
-2,377,451
-38% -$585M 0.16% 135
2022
Q2
$1.89B Sell
6,247,573
-133,485
-2% -$40.4M 0.24% 88
2022
Q1
$2.62B Buy
6,381,058
+139,157
+2% +$57.2M 0.26% 75
2021
Q4
$2.93B Buy
6,241,901
+1,151,427
+23% +$540M 0.26% 79
2021
Q3
$2.16B Sell
5,090,474
-247,898
-5% -$105M 0.2% 106
2021
Q2
$1.92B Buy
5,338,372
+325,327
+6% +$117M 0.18% 121
2021
Q1
$1.41B Buy
5,013,045
+388,798
+8% +$110M 0.14% 165
2020
Q4
$1.31B Buy
4,624,247
+175,527
+4% +$49.7M 0.13% 166
2020
Q3
$1.22B Sell
4,448,720
-842,293
-16% -$232M 0.14% 156
2020
Q2
$1.2B Sell
5,291,013
-28,271
-0.5% -$6.42M 0.15% 145
2020
Q1
$810M Sell
5,319,284
-1,511,705
-22% -$230M 0.13% 168
2019
Q4
$1.03B Sell
6,830,989
-1,914,982
-22% -$288M 0.13% 167
2019
Q3
$1.24B Sell
8,745,971
-154,807
-2% -$22M 0.18% 133
2019
Q2
$1.11B Buy
8,900,778
+130,672
+1% +$16.4M 0.16% 142
2019
Q1
$966M Sell
8,770,106
-224,857
-2% -$24.8M 0.14% 155
2018
Q4
$882M Buy
8,994,963
+57,859
+0.6% +$5.67M 0.15% 143
2018
Q3
$1.1B Sell
8,937,104
-697,773
-7% -$86.2M 0.16% 142
2018
Q2
$957M Sell
9,634,877
-71,736
-0.7% -$7.12M 0.15% 153
2018
Q1
$857M Buy
9,706,613
+397,166
+4% +$35.1M 0.14% 172
2017
Q4
$919M Sell
9,309,447
-81,042
-0.9% -$8M 0.15% 150
2017
Q3
$904M Buy
9,390,489
+104,136
+1% +$10M 0.15% 147
2017
Q2
$878M Sell
9,286,353
-6,009
-0.1% -$568K 0.16% 148
2017
Q1
$758M Sell
9,292,362
-515,827
-5% -$42.1M 0.14% 166
2016
Q4
$832M Buy
9,808,189
+436,134
+5% +$37M 0.17% 149
2016
Q3
$698M Buy
9,372,055
+411,086
+5% +$30.6M 0.14% 172
2016
Q2
$680M Sell
8,960,969
-7,301
-0.1% -$554K 0.14% 170
2016
Q1
$622M Buy
8,968,270
+387,100
+5% +$26.8M 0.13% 180
2015
Q4
$517M Buy
8,581,170
+646,415
+8% +$38.9M 0.11% 204
2015
Q3
$429M Buy
7,934,755
+1,424,259
+22% +$77.1M 0.1% 236
2015
Q2
$378M Buy
6,510,496
+1,377,986
+27% +$80M 0.08% 286
2015
Q1
$309M Buy
5,132,510
+3,201,841
+166% +$193M 0.06% 344
2014
Q4
$103M Sell
1,930,669
-38,722
-2% -$2.06M 0.02% 613
2014
Q3
$88.2M Sell
1,969,391
-24,296
-1% -$1.09M 0.02% 638
2014
Q2
$84.1M Buy
1,993,687
+10,732
+0.5% +$453K 0.02% 686
2014
Q1
$87.3M Sell
1,982,955
-6,085
-0.3% -$268K 0.02% 673
2013
Q4
$97.6M Buy
1,989,040
+39,900
+2% +$1.96M 0.02% 625
2013
Q3
$80.2M Buy
1,949,140
+1,048,870
+117% +$43.2M 0.02% 652
2013
Q2
$63.3M Buy
+900,270
New +$63.3M 0.02% 708